HIVE Digital Technologies reports fiscal 2026 revenue of $297.8 million, driven by Bitcoin mining and high-performance computing growth. HIVE Digital Technologies Ltd. (NASDAQ:HIVE) reported fiscal 2026 revenue of $297.8 million, up 158% year over year, as Bitcoin mining a
Benchmark maintains Buy rating on INDI with $8 target after the company agrees to purchase CMOS image sensor assets for €40 million. Indie Semiconductor (NASDAQ:INDI) will acquire ams OSRAM’s fabless CMOS image sensor business for €40 million. The deal includes €35 million
GoodRx introduces a new subscription plan targeting chronic condition patients to expand its recurring revenue stream. GoodRx (NASDAQ:GDRX) unveiled GoodRx Companion, a $14.99 monthly subscription service aimed at reducing routine healthcare costs for consumers. The offeri
This is why Maravai Lifesciences Holdings Inc. (MRVI) is a Top penny Stock in the Top Investors Portfolio Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) is one of the top penny stocks to buy in investors’ stock portfolio. On May 7, Maravai LifeSciences Holdings Inc. (NAS
Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the top penny stocks to buy in investors' stock portfolio. On May 8, Stifel reiterated a Hold rating on Aclaris Therapeut
Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases Cabaletta Bio Inc. (NASDAQ:CABA) is one of the top penny stocks to buy in investors’ stock portfolio. On May 14, Cabaletta Bio Inc. (NASDAQ:CABA) delivered positive clinic
Denison Mines Corp. (NYSEAMERICAN:DNN) is one of the top penny stocks to buy in investors’ stock portfolio. On May 12, Denison Mines Corp. (NYSEAMERICAN:DNN) reiterated its impressive start to the year Its Phoenix In-Situ Recovery uranium mine became the first large
Allogene Therapeutics, Inc. (NASDAQ:ALLO) is one of the top penny stocks to buy in investors’ stock portfolio. On May 13, Allogene Therapeutics, Inc. (NASDAQ:ALLO) reiterated positive interim results in the ALPHA3 trial of cemacabtagene ansegedleucel (cema-cel), its invest
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the top penny stocks to buy in investors’ stock portfolio. On June 1, research firm Citizens reiterated a Market Outperform rating on Iovanace Biotherapeutics (NASDAQ:IOVA) with a $5 price target Photo from Iovan
Atai Beckley N.V. (ATAI) A Top Penny Stock to Buy Poised to Build Sustained Clinical and Shareholder Value Atai Beckley N.V. (NASDAQ:ATAI) is one of the top penny stocks to buy in investors’ stock portfolio. On May 12, ATAI Beckley (NASDAQ:ATAI) delivered solid first-quart
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.